Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 507

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 507
---
 0.75 |   |
| Expected volatility                |        |   |          1.46 | % |     |   |         0.55 | % |
| Exercise price                     |        | $ |         11.50 |   |     | $ |        11.50 |   |
| Stock price                        |        | $ |         11.67 |   |     | $ |        11.18 |   |
| Dividend Yield                     |        |   |          0.00 | % |     |   |         0.00 | % |
| Expected Term to Maturity Date     |        |   |          4.94 |   |     |   |         5.20 |   |
| Probability of a successful merger |        |   |         90.00 | % |     |   |        90.00 | % |

The following table presents the changes in the fair value of the Level 2 warrant liabilities:

|                                                 |     | Private   
 Placement |         |
|:------------------------------------------------|:----|:----------|--------:|
| Fair value as of December 31, 2023              |     | $         | 447,500 |
| Change in valuation inputs or other assumptions |     |           |       — |
| Fair value as of September 30, 2024             |     | $         | 447,500 |

Changes in valuation inputs or other assumptions are recognized in the change in fair value of warrant liabilities in the statements of operations. NOTE 13. SUBSEQUENT EVENTS The Company evaluated events that have occurred after the balance sheet date up through the date the financial statements was issued. Based upon the review, management did not identify, other than below, any subsequent events that would have required adjustment or disclosure in the financial statements. On October 29, 2024, the Company received written notice from the Staff (the “November Notice”), stating that the Compliance Plan the Company submitted in response to the September 4, 2024 deficiency letter (the “Warrant Letter”) was not accepted as the Company had provided insufficient evidence to demonstrate that it can effect the Compliance Plan by its -monthexpiration date of December 6, 2024 , at which time the Company’s securities will be delisted from Nasdaq, irrespective of the Company’s progress or lack thereof toward regaining compliance with the Rule, and that the Staff had determined to initiate procedures to delist the Company’s warrants from Nas